Guidant gains FDA OK for peripheral cardiac stent:
This article was originally published in Clinica
Executive Summary
The US FDA has approved for sale Guidant's AGILTRAC 0.018 peripheral dilatation catheter for treating patients with peripheral vascular disease (PVD). The device, which is also CE-marked for sale in Europe, is inserted through a small incision to treat blockages in peripheral arteries through a non-surgical, angioplasty procedure. The Indianapolis, Indiana firm said that PVD, a condition that is characterised by blockages in vessels supplying the kidneys and limbs, affects an estimated 10 million patients in the US.